MeiraGTx Presents Preclinical Data on Gene Therapy for Dry AMD
MeiraGTx presented preclinical data on a gene therapy targeting dry age-related macular degeneration.
MeiraGTx presented preclinical data on a gene therapy targeting dry age-related macular degeneration.